Variant report
Variant | nsv1004751 |
---|---|
Chromosome Location | chr3:83179352-83225374 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs11917798 | chr3:83193628-83193629 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs571300982 | chr3:83193651-83193652 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs546075222 | chr3:83193668-83193669 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs547097978 | chr3:83193718-83193719 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs12636715 | chr3:83193719-83193720 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs547240890 | chr3:83193834-83193835 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs138277075 | chr3:83193888-83193889 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs556013387 | chr3:83193924-83193925 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs11917906 | chr3:83193951-83193952 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs538412849 | chr3:83193988-83193989 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs149624848 | chr3:83194001-83194002 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs558040439 | chr3:83194006-83194007 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs368617799 | chr3:83194095-83194096 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs540692123 | chr3:83194096-83194097 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs371591879 | chr3:83194102-83194103 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs180852219 | chr3:83194138-83194139 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs568436267 | chr3:83194167-83194168 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs143949285 | chr3:83194179-83194180 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs186725935 | chr3:83200007-83200008 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs558590348 | chr3:83200040-83200041 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs191577154 | chr3:83200047-83200048 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs553245680 | chr3:83200062-83200063 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs375486043 | chr3:83200085-83200086 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs183259596 | chr3:83200105-83200106 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs536165412 | chr3:83200161-83200162 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs187987308 | chr3:83200165-83200166 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs9850049 | chr3:83200166-83200167 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
28 | rs534825783 | chr3:83200180-83200181 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs114491369 | chr3:83200192-83200193 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs571454321 | chr3:83200208-83200209 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs11278650 | chr3:83200244-83200245 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs78278579 | chr3:83200250-83200251 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs199766138 | chr3:83200251-83200252 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs558329677 | chr3:83200302-83200303 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs578063146 | chr3:83200317-83200318 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs540665300 | chr3:83200327-83200328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs560460424 | chr3:83200353-83200354 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs529147257 | chr3:83200355-83200356 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs553634595 | chr3:83215600-83215601 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs376160434 | chr3:83215621-83215622 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs533880865 | chr3:83215623-83215624 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs577039620 | chr3:83215687-83215688 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs367608145 | chr3:83215688-83215689 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs146267096 | chr3:83215700-83215701 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs551693045 | chr3:83215728-83215729 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs185355439 | chr3:83215744-83215745 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs555642698 | chr3:83215761-83215762 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs536160479 | chr3:83215782-83215783 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs555891202 | chr3:83215790-83215791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs7622155 | chr3:83215801-83215802 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Melanoma | 18172304 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Wilms tumour | 21544195 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Mental retardation | 17124404 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Autism | 20808228 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Medulloblastoma | 16783165 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:83193600-83194200 | Enhancers | Dnd41 | blood |
2 | chr3:83200000-83200400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
3 | chr3:83215600-83216000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
4 | chr3:83215600-83216200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
5 | chr3:83215800-83216400 | Enhancers | H1 Cell Line | embryonic stem cell |